Viatris Inc.

VTRS · Healthcare

$17.33
+1.15% today

What a holder would want to know before buying VTRS: where the price sits in its own history, how far it has fallen before and whether it recovered, and what the business behind it earns. All of it is arithmetic over free market data — no opinions, no recommendations.

Where the price sits
Low $9.74 · Oct 2025High $18.27 · Sep 2026

Today’s price is 81% above the lowest point of the past year and 3% below the highest.

Over the past year it was cheaper than today on 96% of days and more expensive on 4%. Over the last 10 years: cheaper on 63% of days.

14% above its average price of the last 200 trading days.

How bad does it get

Fell 20% or more once in 10 years. The deepest fall was 85%. None has recovered yet.

It is in one now: 65% below the Aug 2016 peak.

Aug 2016
−85%not back yet
What you own

Viatris Inc. · Healthcare · Drug Manufacturers - Specialty & Generic · a large company worth $20.26B

Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.…

Is it making money?
2022
2023
2024
2025

revenue profit

Sales of $14.30B in 2025, and a loss of $3.51B. Sales grew in 0 of the last 3 years.

Loses money on its sales at the moment.

Is it healthy?
Cash
$1.51B
Debt
$13.62B
Free cash flow / yr
$2.68B

Would need about 5.1 years of free cash flow to repay all its debt.

Is it expensive?

Not profitable over the last year. You pay $7 for every $1 of profit expected next year.

A high number means buyers expect growth; a low one means they expect little, or fear trouble. Large US companies have averaged roughly 15–20 over the decades.

Pays 2.75% a year in dividends at today’s price · next ex-dividend Aug 21.

What others are doing

12 analysts: 7 say buy, 4 hold, 1 sell. Their average 12-month target is $19.70 (range $13.00–$26.00).

Insiders made 0 purchases and 0 sales in the last 6 months.

Free data from Yahoo Finance, refreshed daily. This is evidence about the business and its price history, not a recommendation.

Now try it without risking anything

Poshkan is paper trading: real prices, virtual money. Buy VTRS with $10,000 that isn’t real, set a stop before you enter, and find out what your idea would actually have done.

Data from Yahoo Finance, refreshed hourly. Nothing here is financial advice. Poshkan is a paper-trading simulator — all money, trades and returns are virtual.